Cargando…
Supplementation with α-ketoglutarate improved the efficacy of anti-PD1 melanoma treatment through epigenetic modulation of PD-L1
Patients with advanced melanoma have shown an improved outlook after anti-PD1 therapy, but the low response rate restricts clinical benefit; therefore, enhancing anti-PD1 therapeutic efficacy remains a major challenge. Here, our findings showed a significantly increased abundance of α-KG in healthy...
Autores principales: | Liu, Nian, Zhang, Jianglin, Yan, Mingjie, Chen, Lihui, Wu, Jie, Tao, Qian, Yan, Bei, Chen, Xiang, Peng, Cong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9974984/ https://www.ncbi.nlm.nih.gov/pubmed/36854755 http://dx.doi.org/10.1038/s41419-023-05692-5 |
Ejemplares similares
-
Inhibition of TCA cycle improves the anti-PD-1 immunotherapy efficacy in melanoma cells via ATF3-mediated PD-L1 expression and glycolysis
por: Liu, Nian, et al.
Publicado: (2023) -
Eubacterium rectale Improves the Efficacy of Anti-PD1 Immunotherapy in Melanoma via l-Serine-Mediated NK Cell Activation
por: Liu, Nian, et al.
Publicado: (2023) -
Epigenetic Modification of PD-1/PD-L1-Mediated Cancer Immunotherapy against Melanoma
por: Nanamori, Hikaru, et al.
Publicado: (2022) -
Robust immunoscore model to predict the response to anti-PD1 therapy in melanoma
por: Nie, Run-Cong, et al.
Publicado: (2019) -
2015: The Year of Anti-PD-1/PD-L1s Against Melanoma and Beyond
por: Ascierto, Paolo A., et al.
Publicado: (2015)